Regulation of APC Cdh1 E3 ligase activity by the Fbw7/cyclin e signaling axis contributes to the tumor suppressor function of Fbw7

Cell Research

Volumn 23, Issue 7, 2013, Pages 947-961

  Lau, Alan W ^a   Inuzuka, Hiroyuki ^a   Fukushima, Hidefumi ^a   Wan, Lixin ^a   Liu, Pengda ^a   Gao, Daming ^a   Sun, Yi ^b   Wei, Wenyi ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cdh1; cyclin E; Fbw7; tumorigenesis; ubiquitination

Indexed keywords

CYCLIN E; FIZZY RELATED PROTEIN; UBIQUITIN PROTEIN LIGASE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CARCINOGENESIS; CELL LINE; CELL MOTION; GENETICS; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UBIQUITINATION;

ANIMALS; CARCINOGENESIS; CDH1 PROTEINS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CYCLIN E; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MALE; MICE; MODELS, BIOLOGICAL; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITINATION;

EID: 84879880079     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2013.67     Document Type: Article

References (56)

1. Bakhoum SF, Compton DA. Cancer: CINful centrosomes. Curr Biol 2009; 19:R642-R645.
2. Bannon JH, Mc Gee MM. Understanding the role of aneu-ploidy in tumorigenesis. Biochem Soc Trans 2009; 37:910-913.
3. Schvartzman JM, Sotillo R, Benezra R. Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer 2010; 10:102-115.
4. Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006; 6:369-381.
5. Cardozo T, Pagano M. The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol 2004; 5:739-751. (Pubitemid 39208183)
6. Nakayama KI, Nakayama K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin Cell Dev Biol 2005; 16:323-333.
7. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and dif-ferentiation. Nat Rev Cancer 2008; 8:83-93. (Pubitemid 351161321)
8. Spruck CH, Strohmaier H, Sangfelt O, et al. hCDC4 gene mutations in endometrial cancer. Cancer Res 2002; 62:4535-4539.
9. Bai C, Sen P, Hofmann K, et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 1996; 86:263-274. (Pubitemid 26286109)
10. Petroski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 2005; 6:9-20. (Pubitemid 40064895)
11. Hao B, Oehlmann S, Sowa ME, Harper JW, Pavletich NP. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phos-phorylated substrate recognition by SCF ubiquitin ligases. Mol Cell 2007; 26:131-143. (Pubitemid 46550934)
12. Orlicky S, Tang X, Willems A, Tyers M, Sicheri F. Structural basis for phosphodependent substrate selection and orienta-tion by the SCFCdc4 ubiquitin ligase. Cell 2003; 112:243-256. (Pubitemid 36144113)
13. Minella AC, Clurman BE. Mechanisms of tumor suppression by the SCF(Fbw7). Cell Cycle 2005; 4:1356-1359.
14. Akhoondi S, Sun D, von der Lehr N, et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res 2007; 67:9006-9012. (Pubitemid 47535882)
15. Enders GH. Cyclins in breast cancer: too much of a good thing. Breast Cancer Res 2002; 4:145-147. (Pubitemid 35012322)
16. Malyukova A, Dohda T, von der Lehr N, et al. The tumor sup-pressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Cancer Res 2007; 67:5611-5616. (Pubitemid 46984990)
17. Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 2001; 413:316-322. (Pubitemid 32905853)
18. Thompson BJ, Buonamici S, Sulis ML, et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leu-kemia. J Exp Med 2007; 204:1825-1835. (Pubitemid 47236320)
19. O'Neil J, Grim J, Strack P, et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 2007; 204:1813-1824. (Pubitemid 47236319)
20. Onoyama I, Tsunematsu R, Matsumoto A, et al. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med 2007; 204:2875-2888. (Pubitemid 350179557)
21. Rajagopalan H, Jallepalli PV, Rago C, et al. Inactivation of hCDC4 can cause chromosomal instability. Nature 2004; 428:77-81. (Pubitemid 38332360)
22. Minella AC, Swanger J, Bryant E, Welcker M, Hwang H, Clurman BE. p53 and p21 form an inducible barrier that pro-tects cells against cyclin E-cdk2 deregulation. Curr Biol 2002; 12:1817-1827. (Pubitemid 35273901)
23. Loeb KR, Kostner H, Firpo E, et al. A mouse model for cyclin E-dependent genetic instability and tumorigenesis. Cancer Cell 2005; 8:35-47. (Pubitemid 40991813)
24. Zhang H. Life without kinase: cyclin E promotes DNA repli-cation licensing and beyond. Mol Cell 2007; 25:175-176. (Pubitemid 46109616)
25. Keck JM, Summers MK, Tedesco D, et al. Cyclin E overex-pression impairs progression through mitosis by inhibiting APC(Cdh1). J Cell Biol 2007; 178:371-385. (Pubitemid 47196147)
26. Garcia-Higuera I, Manchado E, Dubus P, et al. Genomic sta-bility and tumour suppression by the APC/C cofactor Cdh1. Nat Cell Biol 2008; 10:802-811. (Pubitemid 351927709)
27. Burton JL, Solomon MJ. D box and KEN box motifs in bud-ding yeast Hsl1p are required for APC-mediated degradation and direct binding to Cdc20p and Cdh1p. Genes Dev 2001; 15:2381-2395. (Pubitemid 32899742)
28. Pfeger CM, Kirschner MW. The KEN box: an APC recogni-tion signal distinct from the D box targeted by Cdh1. Genes Dev 2000; 14:655-665. (Pubitemid 30176820)
29. Li M, Zhang P. The function of APC/CCdh1 in cell cycle and beyond. Cell Div 2009; 4:2.
30. Skaar JR, Pagano M. Cdh1: a master G0/G1 regulator. Nat Cell Biol 2008; 10:755-757. (Pubitemid 351927702)
31. Wasch R, Engelbert D. Anaphase-promoting complex-depen-dent proteolysis of cell cycle regulators and genomic instabil-ity of cancer cells. Oncogene 2005; 24:1-10. (Pubitemid 40143858)
32. Wasch R, Robbins JA, Cross FR. The emerging role of APC/CCdh1 in controlling differentiation, genomic stability and tumor suppression. Oncogene 2010; 29:1-10.
33. Engelbert D, Schnerch D, Baumgarten A, Wasch R. The ubiq-uitin ligase APC(Cdh1) is required to maintain genome integ-rity in primary human cells. Oncogene 2008; 27:907-917. (Pubitemid 351225382)
34. Ross KE, Cohen-Fix O. The role of Cdh1p in maintaining genomic stability in budding yeast. Genetics 2003; 165:489-503. (Pubitemid 37337619)
35. Wang X, Di K, Zhang X, et al. Id-1 promotes chromosomal instability through modifcation of APC/C activity during mi-tosis in response to microtubule disruption. Oncogene 2008; 27:4456-4466.
36. Shim EH, Johnson L, Noh HL, et al. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate. Cancer Res 2003; 63:1583-1588. (Pubitemid 36373647)
37. Gstaiger M, Jordan R, Lim M, et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA 2001; 98:5043-5048. (Pubitemid 32397079)
38. Bischoff JR, Anderson L, Zhu Y, et al. A homologue of Dro-sophila aurora kinase is oncogenic and amplifed in human colorectal cancers. EMBO J 1998; 17:3052-3065. (Pubitemid 28254378)
39. Eckerdt F, Yuan J, Strebhardt K. Polo-like kinases and onco-genesis. Oncogene 2005; 24:267-276.
40. Liao C, Wang XY, Wei HQ, et al. Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1. Proc Natl Acad Sci USA 2001; 98:6853-6858. (Pubitemid 32538306)
41. Gao D, Inuzuka H, Tseng A, Chin RY, Toker A, Wei W. Phos-phorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat Cell Biol 2009; 11:397-408.
42. Inuzuka H, Tseng A, Gao D, et al. Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase. Cancer Cell 2010; 18:147-159.
43. Gao C, Guo H, Downey L, Marroquin C, Wei J, Kuo PC Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells. Carcinogenesis 2003; 24:1871-1878. (Pubitemid 38016163)
44. Lukas C, Sorensen CS, Kramer E, et al. Accumulation of cy-clin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature 1999; 401:815-818.
45. Hsu JY, Reimann JD, Sorensen CS, Lukas J, Jackson PK. E2F-dependent accumulation of hEmi1 regulates S phase en-try by inhibiting APC(Cdh1). Nat Cell Biol 2002; 4:358-366. (Pubitemid 34521031)
46. Qiao X, Zhang L, Gamper AM, Fujita T, Wan Y APC/C-Cdh1: from cell cycle to cellular differentiation and genomic integrity. Cell Cycle 2010; 9:3904-3912.
47. Levine AJ. p53, the cellular gatekeeper for growth and divi-sion. Cell 1997; 88:323-331. (Pubitemid 27131374)
48. Riley T Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9:402-412. (Pubitemid 351574202)
49. Sabatini DM. mTOR and cancer: insights into a complex rela-tionship. Nat Rev Cancer 2006; 6:729-734. (Pubitemid 44286004)
50. Wei W, Ayad NG, Wan Y Zhang GJ, Kirschner MW, Kaelin WG, Jr. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 2004; 428:194-198. (Pubitemid 38374317)
51. Boehm JS, Hession MT, Bulmer SE, Hahn WC. Transforma-tion of human and murine fbroblasts without viral oncopro-teins. Mol Cell Biol 2005; 25:6464-6474. (Pubitemid 41023222)
52. Lu K, Yin X, Weng T, et al. Targeting WW domains linker of HECT-type ubiquitin ligase Smurf1 for activation by CKIP-1. Nat Cell Biol 2008; 10:994-1002.
53. Wu T Merbl Y, Huo Y Gallop JL, Tzur A, Kirschner MW. UBE2S drives elongation of K11-linked ubiquitin chains by the anaphase-promoting complex. Proc Natl Acad Sci USA 2010; 107:1355-1360.
54. Chin YR, Toker A. The actin-bundling protein palladin is an Akt1-specifc substrate that regulates breast cancer cell migra-tion. Mol Cell 2010; 38:333-344.
55. Gao D, Inuzuka H, Korenjak M, et al. Cdh1 regulates cell cycle through modulating the claspin/Chk1 and the Rb/E2F1 pathways. Mol Biol Cell 2009; 20:3305-3316.
56. Bazarov AV, Adachi S, Li SF, Mateyak MK, Wei S, Sedivy JM. A modest reduction in c-myc expression has minimal ef-fects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation. Cancer Res 2001; 61:1178-1186. (Pubitemid 32174441)